logo
  

Teleflex Gains 10% After Q3 Results Surpass Estimates

Shares of medical devices company Teleflex Incorporated (TFX) are rising more than 10% Thursday morning after reporting third-quarter results, above the Street view. The company also narrowed full-year revenue outlook, that comes in above consensus estimates.

Net income in the third quarter increased to $137.14 million or $2.90 per share from $101.89 million or $2.16 per share a year ago, mainly due to higher revenue.

Excluding one-time items, earnings from continuing operations of $3.64 per share beat the average estimate of analysts polled by Thomson-Reuters of $3.27 per share.

Revenue for the quarter grew to $746.39 million from $686.79 million last year. The consensus estimate was for $733.56 million.

For the full year, the the company now expects adjusted earnings per share from continuing operations to be in the range of $13.30-$13.50, compared with the previous guidance of $13.00-$13.60. Analysts expect earnings of $13.26 per share.

TFX is at $206.26 currently. It has traded in the range of $177.63 - $276.43 in the last 1 year.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.

Comments from the Fed Chair Jerome Powell were in focus this week that also saw the release of latest inflation figures for the U.S. economy. Find out what Powell said and why those remarks underpinned investor sentiment. In Asia, Japan released first quarter GDP figures. Explore how that served to cloud the outlook for Bank of Japan interest rates. In Europe, some key figures for the U.K. labor market were released.

View More Videos
Follow RTT